{"id":10882,"date":"2013-10-22T09:30:31","date_gmt":"2013-10-22T13:30:31","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=10882"},"modified":"2013-10-22T09:30:50","modified_gmt":"2013-10-22T13:30:50","slug":"opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882","title":{"rendered":"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/22\/2013 (wallstreetpr) &#8211;\u00a0The future looks very promising for Opko Health Inc. (NYSE:OPK) and its investors. The company has obtained a milestone in securing final marketing authorization for its citicoline drug in Spain. The company announced on Monday, October 21, that its subsidiary in Barcelona, Pharmadiet, S.L.U., has received final marketing approval from the Spain\u2019s health authority. This means that the company now has due authorization for commercialization of its injectable and oral formulations of citicoline.<\/p>\n<p style=\"text-align: justify;\">Now the drug company is set to begin citicoline products commercialization in Spain in the course of Q1.14. With this commercialization, OPKO has indicated that its subsidiary in Barcelona, Pharmadiet, will realize significant increase in its sales and earnings, which is definitely good news to the investor community.<\/p>\n<p style=\"text-align: justify;\">That the company is poised for better things with commercialization of citicoline can be seen in the sales of other citicoline products such as <i>Somazina<\/i>\u00ae that is already available in Spain. It is reported that this product exceeded $80 million in sales in 2012. Generally, citicoline enjoys strong sales in Latin America and all those other OPKO emerging markets.<\/p>\n<p style=\"text-align: justify;\">Citicoline products are intended to help in a wide range of treatments. They are targeted for disorders such as memory, stroke related behavior, chronic diseases, head injuries and brain degeneration. This line of treatment basically tweaks in an enhancing manner of phosphatidylcholine in the brain.<\/p>\n<p style=\"text-align: justify;\">As a multi-national biopharmaceutical and diagnostics company, OPKO has focus on leveraging recovery, development and commercialization of medical solutions. The company boasts novel and proprietary technologies in this endeavor.<\/p>\n<p style=\"text-align: justify;\">The company currently carries a buy rating from both Jefferies Group and Barrington Research. Jefferies Group has price objective of $10 on the company\u2019s shares. OPKO currently has $4.31 billion in market cap, having dropped by 7.93% to settle at $10.68 Monday, October 21. The drug manufacturer has its Q3.13 coming up on November 4.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/22\/2013 (wallstreetpr) &#8211;\u00a0The future looks very promising for Opko Health Inc. (NYSE:OPK) and its investors. The company has obtained a milestone in securing [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":10883,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[1601,3436,3257,1602],"stock_ticker":[],"class_list":["post-10882","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nyseopk","tag-opk","tag-opko-health-inc","tag-opko-health-inc-nyseopk","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/22\/2013 (wallstreetpr) &#8211;\u00a0The future looks very promising for Opko Health Inc. (NYSE:OPK) and its investors. The company has obtained a milestone in securing [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-10-22T13:30:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-10-22T13:30:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain\",\"datePublished\":\"2013-10-22T13:30:31+00:00\",\"dateModified\":\"2013-10-22T13:30:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882\"},\"wordCount\":321,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg\",\"keywords\":[\"NYSE:OPK\",\"OPK\",\"Opko Health Inc.\",\"Opko Health Inc. (NYSE:OPK)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882\",\"name\":\"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg\",\"datePublished\":\"2013-10-22T13:30:31+00:00\",\"dateModified\":\"2013-10-22T13:30:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882","og_locale":"en_US","og_type":"article","og_title":"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain - Wall Street PR","og_description":"Boston, MA 10\/22\/2013 (wallstreetpr) &#8211;\u00a0The future looks very promising for Opko Health Inc. (NYSE:OPK) and its investors. The company has obtained a milestone in securing [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-10-22T13:30:31+00:00","article_modified_time":"2013-10-22T13:30:50+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain","datePublished":"2013-10-22T13:30:31+00:00","dateModified":"2013-10-22T13:30:50+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882"},"wordCount":321,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg","keywords":["NYSE:OPK","OPK","Opko Health Inc.","Opko Health Inc. (NYSE:OPK)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882","url":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882","name":"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg","datePublished":"2013-10-22T13:30:31+00:00","dateModified":"2013-10-22T13:30:50+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/467.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/opko-health-inc-nyseopk-secures-final-citicoline-marketing-authorization-in-spain-10882#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Opko Health Inc. (NYSE:OPK) Secures Final Citicoline Marketing Authorization In Spain"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/10882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=10882"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/10882\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/10883"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=10882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=10882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=10882"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=10882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}